Similar articles

• Efficacy of tiotropium in the prevention of exacerbations of COPD.

  Anzueto A, Miravitlles M. Anzueto A, et al. Ther Adv Respir Dis. 2009 Jun;3(3):103-11. doi: 10.1177/1753465809338854. Epub 2009 Jul 17. Ther Adv Respir Dis. 2009. PMID: 19617284 Review.
• Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial.

  Fukuchi Y, Fernandez L, Kuo HP, Mahayiddin A, Celli B, Decramer M, Kesten S, Liu D, Tashkin D. Fukuchi Y, et al. Respirology. 2011 Jul;16(5):825-35. doi: 10.1111/j.1440-1843.2011.01982.x. Respirology. 2011. PMID: 21539680 Clinical Trial.
• Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

  Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM; POET-COPD Investigators. Vogelmeier C, et al. N Engl J Med. 2011 Mar 24;364(12):1093-1103. doi: 10.1056/NEJMoa1008378. N Engl J Med. 2011. PMID: 21428765 Clinical Trial.
• Cost-effectiveness analysis of roflumilast/tiotropium therapy versus tiotropium monotherapy for treating severe-to-very severe COPD.

  Sun SX, Marynchenko M, Banerjee R, Cheng D, Mocarski M, Yin D, Yu AP, Wu EQ. Sun SX, et al. J Med Econ. 2011;14(6):805-15. doi: 10.3111/13696998.2011.623204. Epub 2011 Oct 12. J Med Econ. 2011. PMID: 21992217
• [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].

  Beeh KM, Welte T, Buhl R. Beeh KM, et al. Pneumologie. 2003 Sep;57(9):519-25. doi: 10.1055/s-2003-42216. Pneumologie. 2003. PMID: 13680472 Review. German.